无锡药明康德新药开发股份有限公司（股票代码：02359）于2026年9月17日发布公告，宣布根据人民币6,780百万元于2027年到期的美元结算零息可转换债券的转换条款，新增发行H股193.88万股，占转换前公司已发行股本（不包括库藏股）约0.36%。每股发行价格为153港元，合计金额约2.97亿元。
发行完成后，公司已发行股份（不包括库藏股）数量由原本的538,329,166股增至540,267,919股，库藏股维持20,148,900股不变，总发行股本更新至560,416,819股。公司确认，上述股份发行已获得董事会正式授权并遵守了香港联合交易所有限公司证券上市规则及相关法律法规。
本公告由董事李革签署。公司强调将继续严格遵守各项监管规定，持续关注资本市场动态并保持信息披露的及时和透明。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.